DOMA Perpetual nominates three directors for Pacira board after taking 7.1% stake

Reuters03-12 01:07
DOMA Perpetual nominates three directors for Pacira board after taking 7.1% stake

DOMA Perpetual, which said it owns about 7.1% of Pacira’s common shares, nominated three director candidates for the board: Christopher Dennis, Oliver Benton Curtis and Eric de Armas. DOMA said the stock is down 56% over the last decade and down 68% over the last five years. It also called for CEO Frank Lee to be replaced and for the board to name an interim CEO. DOMA urged the board to engage bankers and run a sale process for the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202603111306PR_NEWS_USPR_____FL08024) on March 11, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment